Moderna's mRNA Flu Vaccine Receives FDA Advisory Panel's Approval

SentiSense · Published · Updated

Moderna's mRNA flu vaccine has received strong backing from an FDA advisory panel, with option trading surging as a result. The approval is expected t...

Sign in to read the full story. Free accounts include 20 full reads a month.

Sign in or create a free account

Powered by SentiSense - Intelligent Market Analysis